Correlation Between Inovio Pharmaceuticals and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Cardiff Oncology, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Cardiff Oncology.
Diversification Opportunities for Inovio Pharmaceuticals and Cardiff Oncology
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inovio and Cardiff is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Inovio Pharmaceuticals and Cardiff Oncology
Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to under-perform the Cardiff Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Inovio Pharmaceuticals is 1.83 times less risky than Cardiff Oncology. The stock trades about -0.19 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 211.00 in Cardiff Oncology on September 6, 2024 and sell it today you would earn a total of 30.00 from holding Cardiff Oncology or generate 14.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Inovio Pharmaceuticals vs. Cardiff Oncology
Performance |
Timeline |
Inovio Pharmaceuticals |
Cardiff Oncology |
Inovio Pharmaceuticals and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inovio Pharmaceuticals and Cardiff Oncology
The main advantage of trading using opposite Inovio Pharmaceuticals and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |